Abstract
Scientists who gathered at the most recent Keystone Symposia meeting on malaria described several advances, including applications of new technologies as well as new insights into pathogenesis and immunology. Enhanced tools to visualize the immune response to the Plasmodium pathogen, and systems biology approaches to interrogate host–parasite interactions, are altering our understanding of immunity and disease. At the same time, a partially effective subunit vaccine in human trials, and new models of highly protective human immunity, are raising expectations for immunological control of this ancient pandemic.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.